9-(2-oxacycloalkyl)-9H-purine-2,6-diamine Derivatives And Their Use For The Treatment Of Skin Disorders
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F23%3A73622371" target="_blank" >RIV/61989592:15310/23:73622371 - isvavai.cz</a>
Alternative codes found
RIV/61989592:15640/23:73622371
Result on the web
<a href="https://patentimages.storage.googleapis.com/07/6e/9d/dd4943ad19a3e9/US11643413.pdf" target="_blank" >https://patentimages.storage.googleapis.com/07/6e/9d/dd4943ad19a3e9/US11643413.pdf</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
9-(2-oxacycloalkyl)-9H-purine-2,6-diamine Derivatives And Their Use For The Treatment Of Skin Disorders
Original language description
The invention concerns N2, N6-disubstituted derivatives of 9- (2-oxacycloalkyl) -9H-purine-2,6-diamine and their use as medicaments and cosmetics. The compounds of the invention report a variety of biological activities related to inhibiting oxidative stress, particularly against aging, anti-inflammatory, and neuro-degenearation. The invention also concerns cosmetic and pharmaceutical compositions containing these derivatives as active compounds.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
—
OECD FORD branch
10401 - Organic chemistry
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
11643413
Publisher
US001 -
Publisher name
United States Patent and Trademark Office (USPTO)
Place of publication
Alexandria
Publication country
US - UNITED STATES
Date of acceptance
May 9, 2023
Owner name
Univerzita Palackého v Olomouci
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence